Join an interactive live webinar examining real-world challenges and evidence-based strategies to optimize HER2 testing and treatment decision-making in advanced and metastatic non-small cell lung cancer (NSCLC).

Learn how healthcare providers and wellness professionals can offer GLP-1 and peptide therapies through compliant, low-overhead models that expand services and improve patient outcomes.

Embark on the path to become an expert injector!  This program provides you with the knowledge and practical skills needed to succeed.  Class size is limited to 8, ensuring you receive an individualized training environment.  Models are provided.

The course integrates the science of precision Self-care, the wisdom of the 8 Principle Patterns of Traditional Chinese medicine philosophy, and the art of herbal medicine making. $349 - 14 hours

This TeleECHO series provides a comprehensive overview of current and emerging therapies for spondyloarthritis (SpA) conditions, translating the latest clinical data and guideline recommendations into practical, real-world applications for HCPs.

This TeleECHO series provides a comprehensive overview of current and emerging therapies for spondyloarthritis (SpA) conditions, translating the latest clinical data and guideline recommendations into practical, real-world applications for HCPs.

Join us for an engaging live symposium at the ATS 2026 International Conference where you will hear leading RCC experts provide valuable insights related to diagnosis, underlying pathophysiology, and the latest treatment advances on the horizon.

Endocrine resistance remains a key challenge in ER+/HER2- metastatic breast cancer, often driven by acquired ESR1 mutations. Early detection using ctDNA-based testing is essential for optimal integration of next-generation oral SERDs.

Build a compliant, profitable healthcare practice using cutting-edge strategies and tools for sustainable growth.

Join us for a complimentary deep dive into MASLD/SLD—covering NITs for risk stratification, lifestyle and medication management, current MASH therapies, and global/US consensus recommendations, led by expert GI providers and APPs.